Funding opportunities

This is a funding notice board for those looking for assistance in their diagnostics development. This will initially host many UK based funders that fund UK and international teams, but we will be researching and adding more funders based in other countries as well. To add an opportunity, longitude [dot] prize [at] nesta [dot] org [dot] uk (please email us).
To see more funding resources, such as general databases and websites, visit our Resources page

JPIAMR Joint Transnational Call 2019

This call will fund joint transnational research projects addressing the development of diagnostic and surveillance tools, technologies and methods to detect antimicrobial resistance (AMR). Projects should address the diagnosis of AMR infections in clinical and veterinary settings, or the surveillance of AMR in humans, animals and the environment. The call promotes projects with impact in low and...
Antimicrobial Stewardship
Deadline 15 February 2019

MRC - Developmental Pathway Funding Scheme - Mar 19 Entry

The DPFS scheme is a key part of MRCs Translational Research Strategy and supports the translation of fundamental discoveries toward benefits to human health. It funds the pre-clinical development and early clinical testing of novel therapeutics, devices and diagnostics, including “repurposing” of existing therapies. Individual projects can start and finish at any point along the translational...
diagnostics, pre-clinical development, translation
Deadline 28 March 2019

British Society for Antimicrobial Chemotherapy - Research Grants

BSAC supports research projects of relevance to antimicrobial chemotherapy. Priority is given to projects focusing on diagnostics, antimicrobial stewardship, virology, antibiotic adjuvants and molecular mechanisms of antimicrobial resistance.
diagnostics, biomarker, Antimicrobial Stewardship
Duration 12 Months
Deadline 29 November 2018 (Forecast)

PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)

This Funding Opportunity Announcement (FOA), issued by the National Institutes of Health (NIH), the Centers for Disease Control and Prevention (CDC), and the Food and Drug Administration (FDA), invites eligible United States small business concerns (SBCs) to submit Small Business Innovation Research (SBIR) grant applications. United States SBCs that have the research capabilities and...
Small Business
Duration Award periods normally may not exceed 6 months for Phase I and 2 years for Phase II. Applicants are encouraged to propose a project duration period that is reasonable and appropriate for completion of the research projects.
Deadline Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date. Please see the website for additional details.